The STRENGTH Trial
June 2, 2021 | A. Michael Lincoff and C. Michael Gibson discuss CV outcomes with omega-3 carboxylic acids in patients with high vascular risk and atherogenic dyslipidemia. |
Listen to previous episodes | Download via iTunes
Brought to you by: Shockwave |